http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20081654-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8726f713a6d86892687edccfa03d886
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
filingDate 2006-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2009-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PE-20081654-A1
titleOfInvention COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
abstract REFERS TO COMPOUNDS OF FORMULA (I) WHERE U, V AND W ARE EACH CR5 AND N, WHERE R5 IS H OR ALKYL (C1-C6); Q IS NR5, NO OR CR5; L1 IS -NR5C (O) -, -NR5C (O) NR5-, -C (O) NR5-, AMONG OTHERS; L2 IS A LINK, -O-, -NR5C (O) -, -NR5C (O) NR5-, AMONG OTHERS; n IS 0 O 1; m IS 0 TO 4; R1 IS ARYL (C6-C10), HETEROARYL (C5-C10), CYCLOALKYL (C3-C12) OR HETERO CYCLOALKYL (C3-C8) OPTIONALLY SUBSTITUTED WITH HALO, AMINO, NITRO, CN, AMONG OTHERS; R2 IS HALO, AMINO, CN, ALKYL (C1-C6), AMONG OTHERS; R3 IS H O ALKYL (C1-C6); R4 IS H, XR6, XNR5XR6, AMONG OTHERS, WHERE X IS A BOND OR ALKYLENE (C1-C4); R6 IS ARYL (C6-C10), HETEROARYL (C5-C10), CYCLOALKYL (C3-C12) OR HETEROCYCLALKYL (C3-C8) OPTIONALLY SUBSTITUTED WITH ALKYL (C1-C6), OH, CN, AMONG OTHERS. THE PREFERRED COMPOUNDS ARE: 3- (4-METHYL-IMIDAZOL-1-IL) -N- {3- [2-OXO-3- (1H-PYRROL-2-ILMETILENO) -2,3-DIHIDRO-1H-INDOL- 6-ILAMINO] -PHENYL} -5-TRIFLUOROMETHYL-BENZAMIDE, N- [2-OXO-3- (1H-PYRROL-2-ILMETHYLENE) -2,3-DIHYDRO-1H-INDOL-6-IL] -BENZAMIDE, 3- (4-METHYL-IMIDAZOL-1-IL) -N- (3- {3- [2-OXO-3- (1H-PYRROL-2-ILMETILENO) -2,3-DIHIDRO-1H-INDOL-6 -IL] -UREIDO} -PHENYL) -5-TRIFLUORomethyl-BENZAMIDE, AMONG OTHERS. IT ALSO REFERS TO A PHARMACEUTICAL COMPOSITION. SAID COMPOUNDS ARE INHIBITORS OF PROTEIN KINASES BEING USEFUL FOR THE TREATMENT OF LEUKEMIA, BREAST CANCER, OVARY, PROSTATE, SARCOMA
priorityDate 2006-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559484
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3609161

Total number of triples: 12.